Abstract: Various methods are provided for programmatically providing a platform for requesting on-demand services on a consumer device. One example method may comprise receiving a job request, the job request comprising job request parameters, the job request parameters comprising at least a type of service, a location, and a time frame, identifying one or more merchants able to provide the service in accordance with the job request parameters by determining a subset of the plurality of merchants able to provide the service, at the location, within the time frame, causing transmission of a job offer to at least a first merchant of the subset of one or more merchants identified as able to provide the service in accordance with the job request parameters, receiving at least one response, the at least one response from the first merchant from the one or more merchants, and assigning the job to the first merchant.

Abstract: A method performed by a station (STA) for operating in a wireless local area network (WLAN) is provided. The method includes communicating, in an operation mode, with devices in the WLAN including another STA and transmitting, to the another STA, one or more of a data frame or a management frame including a medium access control (MAC) header. The MAC header includes an operation mode field indicating a change in one or more parameters of the operation mode. The method includes transmitting or receiving, based on a determination that the indicated change in the one or more parameters of the operation mode has taken effect, a frame to or from the another STA in accordance with the indicated change in the one or more parameters of the operation mode.

Abstract: Provided are methods and compositions for the delivery of fully human post-translationally modified therapeutic TNF receptor Fc fusions. The fully human post-translationally modified therapeutic TNF receptor Fc fusions may be delivered by gene therapy methods, e.g., as a recombinant adeno-associated virus (rAAV) vector to the appropriate tissue. Also provided are methods of treating ocular indications such as non-infectious uveitis with the fully human post-translationally modified therapeutic TNF receptor Fc fusions.

Abstract: A method for preparing a cooled radiofrequency probe for use to treat tissue of a patient's body includes providing a plurality of cooled radiofrequency probes. Each of the plurality of cooled radiofrequency probes includes an elongate member with a distal region and a proximal region. The distal regions each have an electrically and thermally-conductive energy delivery device for delivering one of electrical and radiofrequency energy to the patient's body. The electrically and thermally-conductive energy delivery devices each have one or more internal lumens for circulating a cooling fluid therethrough and an electrically and thermally-conductive protrusion having a temperature sensing element. The temperature sensing elements of each protrusion extends from a distal end of the energy delivery device. Further, each of the temperature sensing elements has a different length that extends from the distal end of the energy delivery device.

Abstract: A method performed by a multi-multi-link device (MMLD) architecture comprising a plurality of access points (APs) may comprise transmitting a frame, by an AP of the MMLD, wherein the frame may include a multi-multi-link device (MMLD) frame element which indicates that the AP is part of a multi-link device (MLD) that is a MMLD. The frame may comprise a beacon, short beacon, probe response, fast initial link setup (FILS) discovery frame, association response frame, or the like, or any appropriate combination thereof. The MMLD element may comprise one or more of an element identifier, length, MMLD identifier, MMLD media access control (MAC) address, partial reporting field, number of reported MLDs field and/or an MLD info field. The MLD may communicate with other MLDs of the multiple MLDs during a transmit wake time (TWT) service period (SP). The MLD may be in a doze state during non-TWT SPs.

Abstract: Aspects of this technical solution can determine, based on power applied to a vehicle from a source of power and power consumed by the vehicle, an emission metric corresponding to the vehicle, and send a request to a second system, the request to link with an asset based on the emission metric.

Abstract: An apparatus for analyzing a bodily fluid sample of a user, the apparatus has an analysis circuitry comprising at least a coupling reference-electrode (RE), a coupling control-electrode (CE), and a plurality of coupling working-electrodes (WEs) for electrically coupling to a RE, a CE, and a plurality of WEs of the electrochemical-sensor structure for analyzing one or more biomarkers in the bodily fluid sample, and an output for outputting an analytical result of said analysis of the identified one or more biomarkers in the bodily fluid sample. At least one of the coupling WEs is for electrically coupling to at least one of the WEs of the electrochemical-sensor structure that is oversaturated with one or more capture ligands.

Abstract: An object induction system is disclosed for assigning handling parameters to an object. The system includes an analysis system, an association system, and an assignment system. The analysis system includes at least one characteristic perception system for providing perception data regarding an object to be processed. The association system includes an object information database and assigns association data to the object responsive to commonality with any of the characteristic perception data with any of the characteristic recorded data. The assignment system is for assigning programmable motion device handling parameters to the indicia perception data based on the association data, and includes a workflow management system as well as a separate operational controller.

Abstract: Compounds for targeting and agents for imaging, prostate-specific membrane antigen (PSMA) are disclosed. Methods of synthesizing compounds and imaging agents, as well as methods for imaging PSMA are also disclosed. The imaging agents disclosed are suitable for PET and SPECT imaging.

Abstract: The subject matter of this specification can be implemented in, among other things, a method, system, and/or device to receive current metrology data for an operation on a current sample in a fabrication process. The metrology data includes a current value for a parameter at each of one or more locations on the current sample. The method further includes determining a current rate of change of the parameter value for each of the one or more locations. The current rate of change is associated with the current sample. The method further includes identifying one or more violating locations each having an associated current rate of change of the parameter value that is greater than an associated reference rate of change of the parameter value, and identifying an instance of abnormality of the fabrication process based on the one or more violating locations.

Abstract: The subject invention pertains to multimodal chromatography resins comprising anionic and cationic ligands on each resin particle and methods of synthesizing the multimodal chromatography resin by contacting a base with quaternary amines and/or tertiary amines on the surface of a substrate. The multimodal resins can be tuned by changing the ratios of cation to anions. The multimodal chromatography resins can be used for purifying proteins.

Abstract: The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, which inhibit the cellular entry of hepatitis B virus (HBV) and/or hepatitis D virus (HDV) or interfere with the function of the life cycle of HBV and/or HDV and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HBV and/or HDV infection. The invention also relates to methods of treating an HBV and/or HDV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.

Abstract: Compositions useful in medical procedures are described, such as separating tissue layers, e.g., submucosal tissue layers, for removal. In some examples, the compositions may include a pharmaceutically acceptable carrier fluid and one or more biocompatible materials at least partially or completely dissolved or suspended in the pharmaceutically acceptable carrier fluid. The one or more biocompatible materials may be chosen from polymers, phospholipids, nanoclays, or combinations thereof. Advantageously, the compositions may be formulated as a solution, emulsion, gel, or suspension capable of being injected into tissue.

Abstract: Provided are methods for delivering lipid nanoparticles (LNPs) to a lung cell of a subject suffering from or at risk for primary ciliary dyskinesia (PCD), wherein the method comprises nebulizing a liquid pharmaceutical composition to generate an aerosolized pharmaceutical composition, and administering the aerosolized pharmaceutical composition to the subject.

Abstract: Disclosed are nano/micromotor devices, systems, and methods for providing payloads in the gastrointestinal system. In one aspect, a micromotor for a gastrointestinal tract includes a micromotor body including a one or more material layers to provide a structure that surrounds a hollow interior region and has an opening to an exterior of the micromotor body; one or more particles including a biocompatible metal element, the one or more particles contained in the interior region of the micromotor body; a coating coupled to the structure of the micromotor body; and a payload material, in which the micromotor is structured to move in a fluid of a gastrointestinal system based on a reaction between the one or more particles and a constituent or a condition of the fluid, such that the reaction generates bubbles that accelerate out of the opening of the micromotor body to propel the micromotor in the fluid.

Abstract: Aspects of the subject disclosure may include, for example, a local server coupled to a plurality of client devices. The local server may receive encrypted content from one or more content sources and provide the content to the client devices. The local server and client devices may be part of a multi-client environment such as a hotel or conference center. The local server does not decrypt and re-encrypt content, thereby allowing the use of low cost equipment. Other embodiments are disclosed.

Abstract: Kidney stone removal system is disclosed having components including a handle mechanism, a nozzle tip, and a guiding device. The handle mechanism employs a trigger that enables control of irrigation and vacuum/suction. Depression of a trigger in the trigger mechanism conveys status of vacuum/suction and irrigation to a user by providing increased resistance at different points of depression. When the trigger is in a home (undepressed) position, irrigation and vacuum/suction are turned off. When the trigger is in a fully depressed position, irrigation and vacuum/suction are turned on. When the trigger is in an intermediate position, irrigation may be turned on, while vacuum/suction remains turned off. The nozzle includes one or more irrigation ports positioned at a distal end of the nozzle and having an irrigation port departure angle of 30 to 60 degrees for directing irrigation fluid forward and laterally from the distal end of the nozzle.

Abstract: Compounds for targeting and agents for imaging, prostate-specific membrane antigen (PSMA) are disclosed. Methods of synthesizing compounds and imaging agents, as well as methods for imaging PSMA are also disclosed. The imaging agents disclosed are suitable for PET and SPECT imaging.

Abstract: Certain aspects of the present disclosure generally relate to electronic circuits and, more particularly, to a power supply circuit and techniques for voltage regulation. One example method for voltage regulation is performed by a switched-mode power supply (SMPS). The method generally includes charging a first capacitive element during a first discharge phase of the SMPS having a first voltage rail and a second voltage rail, the first voltage rail being separate from the second voltage rail. Charging the first capacitive element may include directing a first current to flow from the second voltage rail to a reference potential node through the first capacitive element. In some aspects, the method also includes generating an output voltage at the output node during a first charge phase by directing a second current to flow from the first voltage rail to an inductive element of the SMPS through the first capacitive element.

Abstract: Examples relate to fluid collection devices, and related systems and methods. In some embodiments, a fluid collection device includes an elongated fluid impermeable barrier and an elongated body. The fluid collection device includes at least one of the fluid impermeable barrier being an injection molded fluid impermeable barrier, the body including at least an extruded support, the fluid impermeable barrier including one or more regions of film welded together, the fluid impermeable barrier including a die cut foam fluid impermeable barrier, or the fluid impermeable barrier including a plastic tube welded at the proximal end region and the distal end region.